Please assess the completion status of the following clinical trial:

Trial Title: Insulin Secretion in Diabetes Before and After Glycemic Control

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Aim 1:~  * (non-diabetics)~    * male/female 30-65 yrs old,~   * free of active medical disease,~   * no history of diabetes.~ * (diabetics)~    * HbA1c=6.5-8.5,~   * treated with metformin, a sulfonylurea, or combination,~   * Stable body wt with BMI 28-40.~* Aim 2: Same as above~* Aim 3: Diabetic with HgA1c 8.0-9.5~Exclusion Criteria:~* Aim 1: For both groups: no history of: pancreatitis, cardiac, gastrointestinal, renal or liver disease.~* Aim 2: Same as above~* Aim 3: Same as above, plus a diagnosis of incipient diabetic nephropathy severe nonproliferative, or proliferative retinopathy.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): Intervention: Insulin glargine treatment. The study is designed as a within subjects comparison of insulin secretion in type 2 diabetic patients before and after 2 months of insulin treatment to reduce blood glucose. Insulin secretion will be determined with a hyperglycemic clamp using 20% dextrose, and ingestion of an oral glucose solution (75 g).

Based on this trial design, predict the completion outcome and termination type (if applicable).